Driving ability in patients with psychiatric disorders - Overview and comment on the actual guidelines for road and traffic safety;Verkehrssicherheit bei psychischen störungen: Übersicht und kommentar zu den aktuellen begutachtungsleitlinien zur kraftfahreignung

Nervenheilkunde

Volumn 20, Issue 9, 2001, Pages 511-518

  Soyka, M ^a   Kagerer, S ^a   Gartenmaier, A ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Forensic psychiatry; Psychiatric disorder; Traffic safety

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; FLUVOXAMINE; HYPNOTIC AGENT; MIANSERIN; NEUROLEPTIC AGENT; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TETRACYCLIC ANTIDEPRESSANT AGENT; TRANQUILIZER; TRAZODONE;

AFFECTIVE NEUROSIS; DEMENTIA; DRIVING ABILITY; GERMANY; HUMAN; MENTAL DISEASE; PRACTICE GUIDELINE; PSYCHOMOTOR PERFORMANCE; PSYCHOPHARMACOTHERAPY; REVIEW; SCHIZOPHRENIA; TRAFFIC ACCIDENT; TRAFFIC SAFETY;

EID: 17444438932     PISSN: 07221541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Association of road traffic accidents with benzodiazepine use
2. Wirkungsspektren von cannabis und benzodiazepinen - Ergebnisse von metaanalysen, experimentelle studien
3. The psychopharmacological effects of repeated doses of fluvoxamin, mianserin and placebo in healthy human subjects
4. Practice parameter: Risk of driving and Alzheimer's disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
5. Attention and driving performance in Alzheimer's disease
6. A double-blind comparison of fluoxetine and amitriptyline on cognitive function in elderly depressed patients
7. Alzheimer's disease and driving: Prediction and assessment of driving performance
8. Der kranke mensch im verkehr - Die problematik der psychotropen substanzen
9. Fahreignung psychisch kranker patienten
10. Fahrtauglichkeit unter antidepressiva: Beeinträchtigen serotonin-wiederaufnahmehemmer die fahrtauglichkeit geringer als trizyklische anti-depressiva?
11. The influence of clozapíne and typical neuroleptics on information processing of the central nervous system under clinical conditions in schizophrenic disorders: Implications for fitness to drive
12. Rechtlich relevante medikamentenwirkung im straßenverkehr
13. Critical flicker fusion threshold and anticholinergic effects of chronic antidepressant treatment in remitted depressives
14. Psychose und fahreignung - Entwicklung von kriterien zur klinischen beurteilung
15. Antidepressiva und verkehrssicherheit
16. Antidepressiva und verkehrssicherheit
17. Verkehrs- und alltagssicherheit bei medikation mit citalopram: Analyse der sicherheitsrelevanten leistungsfähigkeit bei 14tägiger einnahme von täglich 20 mg und 40 mg
18. Psychopharmacological effects of sertraline in normal healthy volunteers
19. The effects of paroxetine and other antidepressants in combination with alcohol, in psychomotor activity related to car driving
20. Driving performance in persons with mild senile dementia of the Alzheimer type
21. Dementia and road test performance
22. Can a physican recognize an older driver with increased crash risk potential?
23. Zolpidem and driving impairment
24. Psychopharmaka und fahrtauglichkelt bei älteren patienten
25. Acute and subchronic effects of paroxetine 20 and 40 mg on actual driving, psychomotor performance and subjective assessments in healthy volunteers
26. Parenteral pentazocine: Effects on psychomotor skills and respiration, and interaction with amitriptyline
27. Fahrtauglichkeit unter therapie mit anti-depressiva
28. Psychomotor performance under neuroleptic treatment in schizophrenia - A comparative study on the effect of Haloperidol and Risperidone
29. Crashes and violations among drivers with Alzheimer disease
30. Fluvoxamine does not interact with alcohol or potentiate alcohol-related impairment of cognitive function
31. Residual effects of real car driving performance: Zopiclone versus flunitrazepam and nitrazepam